Clinical Trials Browser

INDUSTRY × Choriocarcinoma × Bevacizumab × Clear all

NCT02664961 2019-07-23

Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)

Phase 2 Terminated

3 enrolled 11 charts

Choriocarcinoma, Trophoblastic Tumor, Placental Site, Gestational Trophoblastic Disease

NCT02396511 2019-06-11

TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

Phase 2 Completed

2 enrolled 10 charts

Choriocarcinoma